Cargando…

Advances in Engineering Cells for Cancer Immunotherapy

Cancer immunotherapy aims to utilize the host immune system to kill cancer cells. Recent representative immunotherapies include T-cell transfer therapies, such as chimeric antigen receptor T cell therapy, antibody-based immunomodulator therapies, such as immune checkpoint blockade therapy, and cytok...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xiao, Li, Teng, Shen, Shiyang, Wang, Jinqiang, Abdou, Peter, Gu, Zhen, Mo, Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831467/ https://www.ncbi.nlm.nih.gov/pubmed/31695806 http://dx.doi.org/10.7150/thno.38583

Ejemplares similares

Recent advances in T-cell engineering for use in immunotherapy
por: Sharma, Preeti, et al.
Publicado: (2016)

Genetically engineered T cells for cancer immunotherapy
por: Li, Dan, et al.
Publicado: (2019)

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
por: Pang, Zhi, et al.
Publicado: (2023)

Adipocytes Encapsulating Telratolimod Recruit and Polarize Tumor‐Associated Macrophages for Cancer Immunotherapy
por: Wen, Di, et al.
Publicado: (2022)

The Multi-Purpose Tool of Tumor Immunotherapy: Gene-Engineered T Cells
por: Mo, Zeming, et al.
Publicado: (2017)

Engineered biomaterials for cancer immunotherapy
por: Cai, Lulu, et al.
Publicado: (2020)

Functional bionanomaterials for cell surface engineering in cancer immunotherapy
por: Ma, Sheng, et al.
Publicado: (2021)

Advancing to the era of cancer immunotherapy
por: Wang, Yun, et al.
Publicado: (2021)

Engineering Prodrug Nanomedicine for Cancer Immunotherapy
por: Yang, Bin, et al.
Publicado: (2020)

Cryo-shocked cancer cells for targeted drug delivery and vaccination
por: Ci, Tianyuan, et al.
Publicado: (2020)

Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor
por: Shen, Shiyang, et al.
Publicado: (2023)

Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy
por: Zhang, Tingting, et al.
Publicado: (2022)

Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
por: Zhou, Yang, et al.
Publicado: (2022)

Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
por: Cheng, Qinzhen, et al.
Publicado: (2023)

Advancements in Cancer Immunotherapies
por: Roy, Ruchi, et al.
Publicado: (2022)

Recent Advances in Engineering Nanomedicines for Second Near-Infrared Photothermal-Combinational Immunotherapy
por: Wang, Fengshuo, et al.
Publicado: (2022)

Advances of injectable hydrogel-based scaffolds for cartilage regeneration
por: Li, Jiawei, et al.
Publicado: (2019)

Recent advances in cancer immunotherapy
por: Sun, Qiang, et al.
Publicado: (2021)

Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
por: Wang, Xiao, et al.
Publicado: (2022)

Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer
por: Dorff, Tanya B., et al.
Publicado: (2022)

A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
por: Zhang, Erhao, et al.
Publicado: (2017)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges
por: Jin, Jing, et al.
Publicado: (2020)

Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy
por: Li, Su-Ran, et al.
Publicado: (2022)

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
por: Cartellieri, Marc, et al.
Publicado: (2010)

The prospect of genetically engineering natural killer cells for cancer immunotherapy
por: Poon, Angie Yu Ching, et al.
Publicado: (2022)

Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
por: Han, Ethan Q, et al.
Publicado: (2013)

T cell receptor-engineered T cells for leukemia immunotherapy
por: Zhang, Yikai, et al.
Publicado: (2019)

Engineering magnetic nano-manipulators for boosting cancer immunotherapy
por: Yan, Bin, et al.
Publicado: (2022)

Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy
por: Johnson, Vinith, et al.
Publicado: (2023)

Current status and advances of immunotherapy in nasopharyngeal carcinoma
por: Xu, Jian-Ying, et al.
Publicado: (2022)

Technical advances in NK cell-based cellular immunotherapy
por: Fang, Fang, et al.
Publicado: (2019)

Engineering neoantigen vaccines to improve cancer personalized immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Advances in Engineered Polymer Nanoparticle Tracking Platforms towards Cancer Immunotherapy—Current Status and Future Perspectives
por: Thangam, Ramar, et al.
Publicado: (2021)

Engineering T Cell Development for the Next Generation of Stem Cell-Derived Immunotherapies
por: Michaels, Yale S., et al.
Publicado: (2023)

TCR engineered T cells for solid tumor immunotherapy
por: Zhang, Yikai, et al.
Publicado: (2022)

Localized nuclear reaction breaks boron drug capsules loaded with immune adjuvants for cancer immunotherapy
por: Shi, Yaxin, et al.
Publicado: (2023)

Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
por: Cichocki, Frank, et al.
Publicado: (2023)

Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
por: Yilmaz, Ahmet, et al.
Publicado: (2020)

Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer Immunotherapies
por: Campisi, Marco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fsnatkq6ko5esh97h7bunpgbu2